Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
0.6199
+0.0341 (5.82%)
At close: Apr 28, 2025, 4:00 PM
0.6262
+0.0063 (1.02%)
Pre-market: Apr 29, 2025, 7:31 AM EDT
Adicet Bio Market Cap
Adicet Bio has a market cap or net worth of $51.26 million as of April 29, 2025. Its market cap has decreased by -72.15% in one year.
Market Cap
51.26M
Enterprise Value
-107.81M
1-Year Change
-72.15%
Ranking
Category
Stock Price
$0.62
Market Cap Chart
Since September 16, 2020, Adicet Bio's market cap has decreased from $301.68M to $51.26M, a decrease of -83.01%. That is a compound annual growth rate of -31.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2025 | 51.26M | -35.34% |
| Dec 31, 2024 | 79.27M | -2.83% |
| Dec 29, 2023 | 81.58M | -78.70% |
| Dec 30, 2022 | 383.09M | -44.04% |
| Dec 31, 2021 | 684.61M | 148.60% |
| Dec 31, 2020 | 275.39M | -8.72% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 787.80B |
| UnitedHealth Group | 382.29B |
| Johnson & Johnson | 373.78B |
| AbbVie | 340.25B |
| Novo Nordisk | 280.41B |
| Abbott Laboratories | 224.65B |
| AstraZeneca | 218.53B |
| Novartis AG | 214.73B |